278 related articles for article (PubMed ID: 21409966)
1. A case of Cinderella: erythema dyschromicum perstans (ashy dermatosis or dermatosis cinecienta).
Muñoz C; Chang AL
Skinmed; 2011; 9(1):63-4. PubMed ID: 21409966
[TBL] [Abstract][Full Text] [Related]
2. Erythema dyschromicum perstans-like eruptions induced by epidermal growth factor receptor inhibitors in patients with lung cancer.
Bang AS; Said JT; Hirner J; Rana J; Pugliese S; Wang JY; Zaba L; Zhao L; Doan L; Smith J; Kwong BY
Support Care Cancer; 2024 May; 32(6):354. PubMed ID: 38750379
[TBL] [Abstract][Full Text] [Related]
3. Erythema dyschromicum perstans.
Tlougan BE; Gonzalez ME; Mandal RV; Kundu RV; Skopicki D
Dermatol Online J; 2010 Nov; 16(11):17. PubMed ID: 21163168
[TBL] [Abstract][Full Text] [Related]
4. [Persistent dyschromic erythema].
Poljacki M; Duran V; Vucković N; Subotić M; Ivkov M; Matić M; Jovanović M
Med Pregl; 1999; 52(3-5):165-8. PubMed ID: 10518404
[TBL] [Abstract][Full Text] [Related]
5. Erythema dyschromicum perstans in children: a report of 14 cases.
Torrelo A; Zaballos P; Colmenero I; Mediero IG; de Prada I; Zambrano A
J Eur Acad Dermatol Venereol; 2005 Jul; 19(4):422-6. PubMed ID: 15987286
[TBL] [Abstract][Full Text] [Related]
6. Multiple linear erythema dyschromicum perstans (ashy dermatosis) in the lines of Blaschko.
Yokozeki H; Ueno M; Komori K; Nishioka K
Dermatology; 2005; 210(4):356-7. PubMed ID: 15942229
[No Abstract] [Full Text] [Related]
7. Case for diagnosis.
Cherobin AC; Oliveira FO; Baeta IG; Vale EC
An Bras Dermatol; 2012; 87(1):151-2. PubMed ID: 22481670
[TBL] [Abstract][Full Text] [Related]
8. Periorbital hyperpigmentation and erythema dyschromicum perstans.
Ing EB; Buncic JR; Weiser BA; de Nanassy J; Boxall L
Can J Ophthalmol; 1992 Dec; 27(7):353-5. PubMed ID: 1490247
[TBL] [Abstract][Full Text] [Related]
9. Clinical and histological aspect of erythema dyschromicum perstans in Korea: A review of 68 cases.
Chang SE; Kim HW; Shin JM; Lee JH; Na JI; Roh MR; Lee JH; Lee GY; Ko JY
J Dermatol; 2015 Nov; 42(11):1053-7. PubMed ID: 26118942
[TBL] [Abstract][Full Text] [Related]
10. Erythema dyschromicum perstans: a case report and review.
Osswald SS; Proffer LH; Sartori CR
Cutis; 2001 Jul; 68(1):25-8. PubMed ID: 11480143
[TBL] [Abstract][Full Text] [Related]
11. [Erythema dyschromicum perstans versus lichen planus].
Leonforte JL; Peláez de di Bari O
Med Cutan Ibero Lat Am; 1987; 15(1):89-92. PubMed ID: 3298889
[TBL] [Abstract][Full Text] [Related]
12. [Chronic toxic erythemo-macular skin hyperpigmentation (erythema dyschromicum perstans, ashy dermatosis].
Samos-Zielińska J; Lańcucki J; Dabrowski J; Sadowska-Iwańciow H
Przegl Dermatol; 1979; 66(4):385-91. PubMed ID: 493562
[No Abstract] [Full Text] [Related]
13. HLA-DR association with the genetic susceptibility to develop ashy dermatosis in Mexican Mestizo patients.
Correa MC; Memije EV; Vargas-Alarcón G; Guzmán RA; Rosetti F; Acuña-Alonzo V; Martínez-Rodríguez N; Granados J
J Am Acad Dermatol; 2007 Apr; 56(4):617-20. PubMed ID: 17116345
[TBL] [Abstract][Full Text] [Related]
14. Letter: Erythema dyschromicum perstans revisited.
Goihman-Yahr M
Dermatol Online J; 2011 Jan; 17(1):14. PubMed ID: 21272505
[TBL] [Abstract][Full Text] [Related]
15. Erythema Dyschromicum Perstans: Response to Topical Tacrolimus.
Mahajan VK; Chauhan PS; Mehta KS; Sharma AL
Indian J Dermatol; 2015; 60(5):525. PubMed ID: 26538750
[TBL] [Abstract][Full Text] [Related]
16. Literature Review of Treatment Outcomes for Lichen Planus Pigmentosus, Erythema Dyschromicum Perstans, and Ashy Dermatosis.
Wu A; Vaidya S
J Cutan Med Surg; 2018; 22(6):643-645. PubMed ID: 30322299
[No Abstract] [Full Text] [Related]
17. Lichen planus pigmentosus-inversus: case report and review of an unusual entity.
Gaertner E; Elstein W
Dermatol Online J; 2012 Feb; 18(2):11. PubMed ID: 22398232
[TBL] [Abstract][Full Text] [Related]
18. Erythema dyschromicum perstans and lichen planus.
Naidorf KF; Cohen SR
Arch Dermatol; 1982 Sep; 118(9):683-5. PubMed ID: 7114873
[TBL] [Abstract][Full Text] [Related]
19. Non-ablative 1550 nm fractional laser therapy not effective for erythema dyschromicum perstans and postinflammatory hyperpigmentation: a pilot study.
Kroon MW; Wind BS; Meesters AA; Wolkerstorfer A; van der Veen JP; Bos JD; Van der Wal AC; Beek JF
J Dermatolog Treat; 2012 Oct; 23(5):339-44. PubMed ID: 21756152
[TBL] [Abstract][Full Text] [Related]
20. [Erythema dyschromicum perstans-ashy dermatosis (EDP-AD). Clinical aspects and problems of classification].
Rotoli M; Stefanato CM; Rezza E
G Ital Dermatol Venereol; 1987 Mar; 122(3):119-20. PubMed ID: 3596645
[No Abstract] [Full Text] [Related]
[Next] [New Search]
